Showing results (51-60 of 74) with videos related to

Sort By:
Pageof 8
Clinical Endocrinology|March 21, 2007
Coronary flow reserve is impaired in patients with adult growth hormone (GH) deficiencyHuseyin Oflaz, Fatma Sen, Ali Elitok, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|October 19, 2014
Diagnostic value of serum M30 and M65 in patients with nasopharyngeal carcinomaFatma Sen, Ibrahim Yildiz, Hatice Odabas, et al.
Medical Oncology (Northwood, London, England)|November 8, 2011
Association of clinical and pathological variables with survival in thymomaAdnan Aydiner, Alper Toker, Fatma Sen, et al.
Cancer Chemotherapy and Pharmacology|June 27, 2013
A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancerIbrahim Yildiz, Faruk Tas, Leyla Kilic, et al.
British Journal of Clinical Pharmacology|May 14, 2011
Effects of safety warnings on prescription rates of cough and cold medicines in children below 2 years of ageE Fatma Sen, Katia M C Verhamme, Mariagrazia Felisi, et al.
Endocrine|January 29, 2008
Coronary flow reserve after L-thyroxine therapy in Hashimoto's thyroiditis patients with subclinical and overt hypothyroidismHuseyin Oflaz, Ramazan Kurt, Fatma Sen, et al.
Epilepsia|October 13, 2009
Comparison of antiepileptic drug prescribing in children in three European countriesYingfen Hsia, Antje Neubert, Miriam C J M Sturkenboom, et al.
Pathology, Research and Practice|January 14, 2024
Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencingSeref Bugra Tuncer, Betul Celik, Seda Kilic Erciyas, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|April 25, 2024
Dose Reduction in Pediatric Oncology Patients with Delayed Total-Body [<sup>18</sup>F]FDG PET/CTClemens Mingels, Benjamin A Spencer, Hande Nalbant, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|April 18, 2014
High serum transforming growth factor beta 1 (TGFB1) level predicts better survival in breast cancerRumeysa Ciftci, Faruk Tas, Ceren Tilgen Yasasever, et al.
Pageof 8